Dermatology E/M coding in 2026 is based on either medical decision making (MDM) or total qualifying time on the date of the encounter. For office and outpatient evaluation and management services, the current CPT framework no longer uses the number of history or physical examination elements to determine the E/M level. Instead, dermatology practices should document medically appropriate clinical information and select the E/M code using the applicable MDM or time requirements. The current office/outpatient E/M revisions originated in 2021 and remain the foundation of the current framework.
For dermatologists, accurate E/M coding is especially important because routine visits can involve multiple skin conditions, prescription drug management, pathology review, diagnostic testing, biopsies, lesion treatment, and other procedures. Understanding how these services interact with MDM, time, modifier 25, and other coding rules can help practices reduce preventable denials while maintaining compliant reimbursement.
What Is Dermatology E/M Coding?
Dermatology E/M coding is the process of selecting the appropriate evaluation and management code for a patient’s office or outpatient encounter based on the services provided, medical necessity, documentation, and either MDM or qualifying total time.
Common office and outpatient E/M code families include:
- 99202–99205: New patient office/outpatient visits
- 99211–99215: Established patient office/outpatient visits
The coding objective should always be accurate representation of the documented service, rather than maximizing the reported E/M level. For dermatology practices that need additional support, specialized medical coding services can help ensure E/M levels, documentation, and billing practices remain accurate and aligned with current coding requirements.
Current Dermatology E/M Coding Guidelines for 2026
For office and outpatient E/M services, physicians and qualified healthcare professionals generally select the level using one of two methods:
- Medical decision making (MDM)
- Total qualifying time on the date of service
When MDM is used, three elements are evaluated:
- Number and complexity of problems addressed
- Amount and/or complexity of data to be reviewed and analyzed
- Risk of complications and/or morbidity or mortality of patient management
These are the current MDM concepts used in the CPT office/outpatient framework. The older point-based approaches found in some legacy coding articles should not be presented as the current method for determining office/outpatient E/M levels.
History and Physical Examination
A common dermatology coding misconception is that documenting more examination findings automatically supports a higher E/M code.
That is no longer how office/outpatient E/M levels are selected.
A dermatologist should still perform and document a medically appropriate history and examination based on the patient’s condition and clinical needs. However, the number of HPI elements, review-of-system items, or examination bullets does not determine the E/M level under the current office/outpatient framework.
This distinction is particularly relevant to dermatology because a full-body skin examination may be clinically appropriate without independently establishing a higher E/M level.
How Is MDM Determined in Dermatology?
1. Number and Complexity of Problems Addressed
The first MDM element considers the problems that were actually evaluated or managed during the encounter.
Dermatology examples may include:
- Worsening psoriasis
- Poorly controlled eczema
- Treatment-resistant acne
- New or changing pigmented lesions
- Suspected skin malignancy
- Drug-related skin reactions
- Chronic dermatologic disease requiring a change in treatment
- Conditions requiring prescription drug management
A diagnosis simply appearing on a problem list does not automatically mean that it contributes to MDM. The medical record should show that the condition was evaluated, treated, monitored, investigated, or otherwise addressed.
For example, documenting “psoriasis” without discussing its current status or management provides limited support. Documentation describing worsening symptoms, prior treatment response, treatment options considered, and the resulting plan provides a clearer record of the medical decision-making performed.
2. Amount and Complexity of Data Reviewed and Analyzed
Dermatology encounters can involve diagnostic and clinical information from multiple sources.
Relevant data may include:
- Pathology and dermatopathology reports
- Laboratory results
- Previous biopsy findings
- External medical records
- Diagnostic studies
- Information obtained from an independent historian
- Other clinically relevant records
The provider’s documentation should make the relevant data review or analysis clear when it contributes to MDM.
For example, reviewing a previous biopsy report and incorporating the findings into a treatment decision can be part of the encounter’s medical decision making when the applicable CPT requirements are satisfied.
Practices should avoid using outdated point-counting systems to calculate data complexity. The current CPT framework uses defined MDM categories rather than the older “one point for a lab, one point for an X-ray” approach found in legacy E/M resources.
3. Risk of Patient Management
The third MDM element addresses the risk associated with management decisions made during the encounter.
In dermatology, examples can include:
- Prescription drug management
- Changes to ongoing prescription therapy
- Treatment requiring appropriate monitoring
- Management decisions involving potentially significant complications
- Treatment planning for serious or complex dermatologic conditions
The presence of a serious diagnosis does not automatically establish high MDM. Likewise, prescribing a medication does not by itself determine the final E/M level.
The provider’s documented management decisions must be evaluated within the complete MDM framework.
Time-Based Dermatology E/M Coding
When time is used to select an office/outpatient E/M level, the relevant physician or qualified healthcare professional time on the date of service is considered according to CPT requirements.
Depending on the service, qualifying activities may include preparing for the encounter, reviewing relevant information, performing the medically appropriate evaluation, counseling and educating the patient or caregiver, ordering medications or tests, communicating with other healthcare professionals when not separately reported, and documenting the encounter.
Current office/outpatient time ranges include:
| CPT Code | Total Time |
|---|---|
| 99202 | 15–29 minutes |
| 99203 | 30–44 minutes |
| 99204 | 45–59 minutes |
| 99205 | 60–74 minutes |
| 99212 | 10–19 minutes |
| 99213 | 20–29 minutes |
| 99214 | 30–39 minutes |
| 99215 | 40–54 minutes |
These ranges apply when time is used to select the E/M level. When MDM is used instead, there is no requirement to document or spend the amount of time associated with the selected E/M level.
For dermatology, time-based coding may be useful for encounters involving extensive treatment counseling, review of prior pathology, complex medication discussions, or care coordination performed on the date of service.
Dermatology E/M Coding With Procedures
One of the most important areas of dermatology billing is determining whether an E/M service can be reported on the same date as a procedure.
A dermatologist may evaluate a patient’s skin condition and perform a biopsy, destruction, excision, injection, or other procedure during the same encounter. However, the presence of a procedure does not automatically justify a separate E/M service.
Modifier 25
Modifier 25 may be appended to an E/M code when the service is significant and separately identifiable from another procedure or service performed on the same date, when the applicable requirements are met. CMS specifically notes that modifier 25 should not be used automatically and that the documentation must support the additional E/M service.
For example, a dermatologist may evaluate worsening acne, change prescription therapy, and separately treat an unrelated actinic keratosis. If the documentation demonstrates a significant, separately identifiable E/M service beyond the work inherent in the procedure, modifier 25 may be appropriate.
CMS has continued to emphasize correct modifier 25 reporting because improper use can result in incorrect Medicare payments.
Modifier 59 and X{EPSU} in Dermatology
Modifier 59 identifies a distinct procedural service when the applicable circumstances and coding requirements are met. It may apply when otherwise bundled procedures represent genuinely distinct services, such as services involving a separate lesion or different site.
CMS explains that modifier 59 should not be used simply to bypass an NCCI edit. Documentation must support the distinct nature of the service. When a more specific modifier is appropriate, that modifier should generally be used instead.
The X modifiers provide greater specificity:
- XE: Separate encounter
- XS: Separate structure
- XP: Separate practitioner
- XU: Unusual non-overlapping service
These modifiers may be particularly relevant when multiple dermatologic procedures are performed during the same encounter, but their use depends on the actual circumstances and applicable NCCI requirements. Modifier 59 should not be appended to an E/M service; modifier 25 addresses a separately identifiable E/M service reported with a non-E/M procedure.
G2211 and Dermatology E/M Coding in 2026
Medicare-participating dermatology practices should also understand HCPCS code G2211, the office/outpatient E/M visit complexity add-on.
G2211 recognizes complexity associated with an ongoing practitioner-patient relationship in which the practitioner serves as a continuing focal point for needed care or provides ongoing management of a single serious or complex condition. CMS emphasizes that the complexity represented by G2211 is related to the longitudinal relationship and responsibility for care—not simply the severity of a diagnosis.
G2211 is reported with an eligible E/M base service and requires medical necessity and appropriate documentation. CMS also provides specific rules for situations involving modifier 25 and preventive services.
Dermatology practices should therefore evaluate G2211 based on the actual nature of the patient-provider relationship rather than treating it as an automatic add-on for complex dermatologic conditions.
Common Dermatology E/M Coding Errors and How to Improve Accuracy
Common E/M errors can cause denials, undercoding, overcoding, and compliance risks. Regular documentation and coding reviews help dermatology practices improve accuracy and protect revenue.
| Coding Error | Best Practice |
|---|---|
| Outdated E/M rules | Use current MDM or qualifying time requirements. |
| Unaddressed diagnoses | Code only conditions actually evaluated or managed. |
| Incorrect MDM level | Base MDM on problems, data, and management risk. |
| Incomplete documentation | Clearly document clinical decisions, treatment, and follow-up. |
| Automatic modifier 25 | Use only when the E/M service is significant and separately identifiable. |
| Incorrect modifier 59 | Use only for genuinely distinct procedural services supported by documentation. |
| Missing time documentation | Document total qualifying time when time determines the E/M level. |
| Payer requirements overlooked | Monitor payer policies, NCCI edits, and denial trends. |
| No regular coding audits | Audit E/M levels, modifiers, documentation, and denials regularly. |
A regular dermatology E/M coding audit can uncover documentation gaps, coding errors, modifier issues, and revenue leakage before they become recurring problems.
Conclusion
Accurate dermatology E/M coding in 2026 is not about choosing the highest possible E/M level. It is about accurately reporting medically necessary services using the current MDM or time-based framework. Dermatology practices should document the conditions actually addressed, relevant data reviewed and analyzed, management decisions, and qualifying time when applicable. When E/M services are performed with biopsies, lesion treatments, excisions, or other procedures, modifier 25 and NCCI-associated modifiers must be applied only when their specific requirements are met.
Let our coding experts review your dermatology billing process and identify opportunities to improve accuracy and revenue.
